Format

Send to:

Choose Destination
See comment in PubMed Commons below
Rev Med Suisse. 2014 Jan 15;10(412-413):101-7.

[Osteoporosis].

[Article in French]

Author information

  • 1Service des maladies osseuses, Département des spécialités de médecine, HUG, 1211 Genève. brigitte.uebelhart@hcuge.ch
  • 2Service des maladies osseuses, Département des spécialités de médecine, HUG, 1211 Genève.

Abstract

The quality of the management of patients with osteoporosis varies by country. The recommendations of the Swiss Association against osteoporosis propose intervention thresholds based on the results of the FRAX tool. Despite increasing number of observational studies with several hundred thousands of patients, it is not possible to conclude to a clear increased risk of cardiovascular disease with calcium intakes. A persistent effect of zoledronic acid is observed even after one single injection. There is no increased fracture risk within 7 months following Denosumab treatment cessation.

PMID:
24558909
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk